You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cabozantinib

Showing 26 - 50 of 252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Prostate Cancer Adenocarcinoma, Non-Metastatic Trial in Durham (Cabozantinib, Radical Prostatectomy)

Terminated
Has Results
  • Prostate Cancer
  • +2 more
  • Cabozantinib
  • Radical Prostatectomy
  • Durham, North Carolina
    Duke University Medical Center
Jun 3, 2022

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Withdrawn
  • BCLC Stage B Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +3 more
  • (no location specified)
Dec 12, 2022

Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,

Not yet recruiting
  • Metastatic Extraskeletal Myxoid Chondrosarcoma
  • +3 more
  • Biopsy
  • +6 more
  • (no location specified)
Apr 25, 2023

Advanced Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in Seattle

Terminated
  • Advanced Hepatocellular Carcinoma
  • +2 more
  • Cabozantinib S-malate
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 12, 2022

Brain Metastases, Renal Cell Carcinoma Trial in Houston (Nivolumab, Ipilimumab, Cabozantinib)

Not yet recruiting
  • Brain Metastases
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

CaboCHECK - Cabozantinib in Adult Advanced Renal Cell Carcinoma

Terminated
  • Advanced Renal Cell Carcinoma (All Subtypes)
  • Metastatic Renal Cell Carcinoma (All Subtypes)
  • Documentation
  • Essen, Nordrhein-Westfalen, Germany
  • +1 more
Dec 21, 2022

Metastatic Renal Cell Carcinoma Trial in France (Cabozantinib)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Cabozantinib
  • Angers, France
  • +8 more
Dec 5, 2022

Meningioma Trial in Miami (Cabozantinib)

Recruiting
  • Meningioma
  • Cabozantinib
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc
Jun 17, 2022

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

Not yet recruiting
  • Metastatic Nasopharyngeal Carcinoma
  • +2 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Jun 13, 2023

Renal Cell Carcinoma Trial in Leiden (Light breakfast)

Not yet recruiting
  • Renal Cell Carcinoma
  • Light breakfast
  • Leiden, Zuid-Holland, Netherlands
    Leids Universitair Medisch Centrum
Jul 4, 2022

Hepatocellular Carcinoma Trial in Barcelona, Madrid, Oviedo (Cabozantinib)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Cabozantinib
  • Barcelona, Spain
  • +5 more
Jul 7, 2022

Advanced Adult Hepatocellular Carcinoma Trial in Chicago, Ann Arbor, Dallas (Cabozantinib)

Recruiting
  • Advanced Adult Hepatocellular Carcinoma
  • Cabozantinib
  • Chicago, Illinois
  • +3 more
Aug 15, 2022

Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma, Stage III Adrenal Cortical Carcinoma AJCC v8

Not yet recruiting
  • Locally Advanced Adrenal Cortical Carcinoma
  • +4 more
  • Atezolizumab
  • +5 more
  • Atlanta, Georgia
  • +1 more
Aug 17, 2023

Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)

Recruiting
  • Metastatic Hormone Refractory Prostate Cancer
  • Cabozantinib
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 6, 2022

Bladder Cancer Trial in United States (Cabozantinib, Atezolizumab, Cystectomy)

Recruiting
  • Bladder Cancer
  • Cabozantinib
  • +2 more
  • Hackensack, New Jersey
  • +4 more
Aug 26, 2022

Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer Trial in Mobile (Cabozantinib 40 MG oral once a day,

Terminated
  • Cervical Cancer
  • +3 more
  • Cabozantinib 40 MG oral once a day
  • Pembrolizumab 200 mg IV every 3 weeks
  • Mobile, Alabama
    University of South Alabama Mitchell Cancer Institute
Jun 3, 2022

Refractory Cutaneous Melanoma Trial in Portland (Ipilimumab, Nivolumab, Cabozantinib)

Recruiting
  • Refractory Cutaneous Melanoma
  • Portland, Oregon
    Providence Portland Medical Center
Jun 8, 2022

Prostate Cancer Trial in Detroit, New York (Cabozantinib)

Recruiting
  • Prostate Cancer
  • Cabozantinib
  • Detroit, Michigan
  • +2 more
Mar 30, 2022

Metastatic Urothelial Carcinoma, Bladder Cancer Trial in Tampa, Atlanta, Salt Lake City (Cabozantinib, Pembrolizumab)

Recruiting
  • Metastatic Urothelial Carcinoma
  • Bladder Cancer
  • Tampa, Florida
  • +2 more
Jun 9, 2022

Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Germany (Cabozantinib)

Recruiting
  • Neuroendocrine Tumors
  • Neuroendocrine Carcinoma
  • Cabozantinib
  • Göttingen, Lower Saxony, Germany
  • +5 more
Jun 27, 2022

Pancreatic Cancer Trial in Lexington (Cabozantinib, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Feb 26, 2022

d To Treat People With Renal Cell Carcinoma

Recruiting
  • Renal Cell Carcinoma
  • Cabozantinib
  • Tokyo, Japan
    Takeda Selected Site
Apr 26, 2022

Carcinoma Prostate Trial in Brescia (Cabozantinib)

Recruiting
  • Carcinoma Prostate
  • Cabozantinib
  • Brescia, Italy
    Alfredo Berruti
Mar 2, 2022

Metastatic Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Philadelphia (Cabozantinib)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Cabozantinib
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Mar 2, 2022

Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma

Active, not recruiting
  • Renal Cell Carcinoma
  • Cabozantinib
  • Padova, Italy
    Istituto Oncologico Veneto
Feb 7, 2022